BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38705028)

  • 1. N0 neck trial: Does intensification of follow-up (Ultrasound + Physical Examination) influence outcomes in early-stage oral cancer?
    Vaish R; Hawaldar R; Gupta S; Dandekar M; Shah S; Chaukar D; Pantvaidya G; Deshmukh A; Chaturvedi P; Pai P; Nair D; Nair S; Thakur M; Ghosh-Laskar S; Agarwal JP; D'Cruz AK
    Eur J Cancer; 2024 Jun; 204():114064. PubMed ID: 38705028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of sentinel lymph node scintigraphy and intraoperative gamma probing with gold standard elective neck dissection in patients with N0 oral squamous cell cancers.
    Sundaram PS; Subramanyam P
    Nucl Med Commun; 2019 Nov; 40(11):1138-1147. PubMed ID: 31568193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival with elective neck dissection in thick early-stage oral squamous cell carcinoma.
    Ebrahimi A; Ashford BG; Clark JR
    Head Neck; 2012 May; 34(5):709-16. PubMed ID: 21739519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.
    D'Cruz AK; Vaish R; Kapre N; Dandekar M; Gupta S; Hawaldar R; Agarwal JP; Pantvaidya G; Chaukar D; Deshmukh A; Kane S; Arya S; Ghosh-Laskar S; Chaturvedi P; Pai P; Nair S; Nair D; Badwe R;
    N Engl J Med; 2015 Aug; 373(6):521-9. PubMed ID: 26027881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trial.
    Miura K; Hirakawa H; Uemura H; Yoshimoto S; Shiotani A; Sugasawa M; Homma A; Yokoyama J; Tsukahara K; Yoshizaki T; Yatabe Y; Matsuo K; Ohkura Y; Kosuda S; Hasegawa Y
    Auris Nasus Larynx; 2017 Jun; 44(3):319-326. PubMed ID: 27496008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer.
    Iype EM; Sebastian P; Mathew A; Balagopal PG; Varghese BT; Thomas S
    Oral Oncol; 2008 Dec; 44(12):1134-8. PubMed ID: 18486527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.
    Schilling C; Stoeckli SJ; Haerle SK; Broglie MA; Huber GF; Sorensen JA; Bakholdt V; Krogdahl A; von Buchwald C; Bilde A; Sebbesen LR; Odell E; Gurney B; O'Doherty M; de Bree R; Bloemena E; Flach GB; Villarreal PM; Fresno Forcelledo MF; Junquera Gutiérrez LM; Amézaga JA; Barbier L; Santamaría-Zuazua J; Moreira A; Jacome M; Vigili MG; Rahimi S; Tartaglione G; Lawson G; Nollevaux MC; Grandi C; Donner D; Bragantini E; Dequanter D; Lothaire P; Poli T; Silini EM; Sesenna E; Dolivet G; Mastronicola R; Leroux A; Sassoon I; Sloan P; McGurk M
    Eur J Cancer; 2015 Dec; 51(18):2777-84. PubMed ID: 26597442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depth of invasion in early oral cancers- is it an independent prognostic factor?
    D'Cruz AK; Dhar H; Vaish R; Hawaldar R; Gupta S; Pantvaidya G; Chaukar D; Chaturvedi P; Pai P; Deshmukh A; Kane S; Nair D; Nair SV; Ghosh-Laskar S; Agarwal J
    Eur J Surg Oncol; 2021 Aug; 47(8):1940-1946. PubMed ID: 33814237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elective neck dissection in T1/T2 oral squamous cell carcinoma with N0 neck: essential or not? A systematic review and meta-analysis.
    Ibrahim SA; Ahmed ANA; Elsersy HA; Darahem IMH
    Eur Arch Otorhinolaryngol; 2020 Jun; 277(6):1741-1752. PubMed ID: 32100133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of clinically node-negative early-stage oral cancer: network meta-analysis of randomized clinical trials.
    Al-Moraissi EA; Alkhutari AS; de Bree R; Kaur A; Al-Tairi NH; Pérez-Sayáns M
    Int J Oral Maxillofac Surg; 2024 Mar; 53(3):179-190. PubMed ID: 37661515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
    O'Brien CJ; Traynor SJ; McNeil E; McMahon JD; Chaplin JM
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):360-5. PubMed ID: 10722009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: a study of the SEER database.
    Wushou A; Yibulayin F; Sheng L; Luo Y; Yang ZC
    BMC Cancer; 2021 Dec; 21(1):1309. PubMed ID: 34876079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a randomized controlled trial of level IIb preserving neck dissection in clinically node-negative squamous carcinoma of the oral cavity.
    Pandey M; Karthikeyan S; Joshi D; Kumar M; Shukla M
    World J Surg Oncol; 2018 Nov; 16(1):219. PubMed ID: 30409212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective Neck Dissection vs Observation in Early-Stage Squamous Cell Carcinoma of the Oral Tongue With No Clinically Apparent Lymph Node Metastasis in the Neck: A Systematic Review and Meta-analysis.
    Abu-Ghanem S; Yehuda M; Carmel NN; Leshno M; Abergel A; Gutfeld O; Fliss DM
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):857-65. PubMed ID: 27442962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the importance of systematic neck dissection in carcinoma of the oral cavity treated by brachytherapy alone for the primary lesion (apropos of a series of 346 patients)].
    Pernot M; Verhaeghe JL; Guillemin F; Carolus JM; Hoffstetter S; Peiffert D
    Bull Cancer Radiother; 1995; 82(3):311-7. PubMed ID: 8554881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for practice and implications for research.
    Gupta T; Maheshwari G; Kannan S; Nair S; Chaturvedi P; Agarwal JP
    Oral Oncol; 2022 Jan; 124():105642. PubMed ID: 34861565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer.
    Ross G; Shoaib T; Soutar DS; Camilleri IG; Gray HW; Bessent RG; Robertson AG; MacDonald DG
    Arch Otolaryngol Head Neck Surg; 2002 Nov; 128(11):1287-91. PubMed ID: 12431172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
    Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
    Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral neck failure in lateralized oral squamous cell carcinoma.
    Habib M; Murgasen J; Gao K; Ashford B; Shannon K; Ebrahimi A; Clark JR
    ANZ J Surg; 2016 Mar; 86(3):188-92. PubMed ID: 26138827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node biopsy for early-stage oral cavity cancer: the VU University Medical Center experience.
    Den Toom IJ; Heuveling DA; Flach GB; van Weert S; Karagozoglu KH; van Schie A; Bloemena E; Leemans CR; de Bree R
    Head Neck; 2015 Apr; 37(4):573-8. PubMed ID: 24677355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.